middle.news
Artrya Advances US Rollout and Nears FDA Submission with $76.6M Cash Backing
9:48am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
Artrya Advances US Rollout and Nears FDA Submission with $76.6M Cash Backing
9:48am on Thursday 30th of April, 2026 AEST
Key Points
Salix platform live across five Tanner Health hospitals
Northeast Georgia and Cone Health preparing FY27 go-live
Coronary Flow module in final clinical validation before FDA submission
SAPPHIRE Study ethics and contracting underway at six US health systems
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE